LBA02-05 NAXIVA - A PHASE II NEOADJUVANT STUDY OF AXITINIB FOR REDUCING EXTENT OF VENOUS TUMOR THROMBUS IN CLEAR CELL RENAL CELL CANCER WITH VENOUS INVASION: TRANSLATIONAL RESULTS | Zendy

AI Assistant Blog Pricing

LBA02-05 NAXIVA - A PHASE II NEOADJUVANT STUDY OF AXITINIB FOR REDUCING EXTENT OF VENOUS TUMOR THROMBUS IN CLEAR CELL RENAL CELL CANCER WITH VENOUS INVASION: TRANSLATIONAL RESULTS

Details

The content you want is available to Zendy users.Already have an account? Click here. to sign in.